RedHill Biopharma Ltd.
METHOD FOR TREATING CANCER WITH COMBINATION THERAPY

Last updated:

Abstract:

Provided are methods for treating cancer in a patient by administering at least one antibiotic selected from the group consisting of clofazimine, rifabutin and clarithromycin, in combination with an aryladamantane compound. In an embodiment, the aryladamantane compound is [3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide], or a pharmaceutically acceptable salt thereof.

Status:
Application
Type:

Utility

Filling date:

17 Sep 2019

Issue date:

16 Apr 2020